Given GC’s potent anti-inflammatory effects, liver-specific activation of GR may protect against HFHS-induced NAFLD and the progression from NAFLD to NASH and cirrhosis. Here, NR3C1 is linked to metabolic dysfunction-associated steatotic liver disease.